Ambetter of Alabama, a product offered by a Centene Corporation (NYSE: CNC) company, a leading healthcare enterprise that provides insurance to under-insured and uninsured populations through the ...
The market faces challenges such as high costs of sophisticated devices and rural preference for traditional methods, but ...
Ambetter from Superior HealthPlan and Ambetter Health, products offered by Centene Corporation (NYSE: CNC), a leading healthcare enterprise that provides insurance to under-insured and uninsured ...
In Nigeria, a silent health crisis is unfolding mdash;diabetes, once thought to be an adult disease, is increasingly ...
As local advocates work to create a syringe exchange program in Evansville, the framework for the whole system is up in the ...
Originally for diabetes, drugs like Ozempic and Mounjaro are now popular for weight loss but experts warn of risks. These ...
The Global Diabetes Devices Market is projected to expand at a compound annual growth rate (CAGR) of approximately 6% by 2026. Key drivers of this growth include the rising incidence of diabetes, ...
The Needle-Free Injection System Market represents a groundbreaking advancement in medical technology, offering an innovative alternative to traditional needle-based drug delivery methods. These ...
GlobalData on MSN
FDA rejects Regeneron’s Eylea HD amid filling facility woes
Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.
The pharmaceutical industry and healthcare advocates are expressing concern that a single-payer pharmacare program could ...
Opinion - In South Africa, two people can live with the same chronic condition yet face vastly different realities.
Groundbreaking diabetes and weight loss drugs like Ozempic and Mounjaro are transforming treatment, offering significant weight loss. However, access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results